Research use only (revision 3)
Old revision·12:30, 6 Aug 2024·StubExpanderSven
This is an old revision of this page, as it stood at 12:30, 6 Aug 2024, saved by StubExpanderSven with the summary add the cross-link to the legal-status-by-jurisdiction list. It may differ substantially from the current revision, and any error it contains may since have been corrected.
| Research use only | |
|---|---|
| Topic infobox · conventions |
Research use only is a label applied by a seller to material offered for laboratory work rather than for administration to humans or animals. The phrase, and its abbreviation RUO, appears on the great majority of research-peptide listings, invoices and certificates.[1]
The label is a commercial and regulatory category, not an approval. Material carrying it has not been assessed by any medicines regulator, is not manufactured under the obligations that apply to medicines, and is not approved for human use in any major jurisdiction. Its identity, purity, sterility and endotoxin content are not assured by anybody outside the supply chain that produced it.[2][3]
References
- ^ Research-use-only labelling practice as described in sellers' own published terms and listings, retrieved 2026, and in the general literature on the category. Self-published primary sources: usable for what sellers state about their own intent and for nothing else.
- ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a quality-system claim would be assessed.
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
Categories: